Browse studies
Find your next paid study
15 recruiting studies matching your filters
Phase 1
A Phase 1/2 Trial of RPTR-1-201, a T Cell Receptor Bispecific Therapy, in Advanced Solid Tumors
This is an early phase trial designed to evaluate the safety, tolerability, and preliminary antitumor activity of RPTR-1-201 in adults with advanced solid tumo…
Advanced Malignant Solid Tumor
Estimated
~$10 – $7,500
Repertoire Immune MedicinesNCT07293754
Phase 1
A Phase I/IIA Study Evaluating the Safety and Efficacy of NY-ESO-1TCR/dnTGFBRII Engineered T Cells in Combination With Decitabine in Subjects With Recurrent or Treatment Refractory Ovarian Cancer and Other Advanced Malignancies
This phase I/IIA trial studies the side effects and best dose of gene-modified T cells when given with or without decitabine, and to see how well they work in …
Ovarian CancerAdvanced Malignant Solid Tumor
Estimated
~$10 – $6,250
University of ChicagoNCT07389239
Observational
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
The purpose of the study is to test a new approach to see if the test results can be reproduced each time the Magnetic resonance imaging (MRI) is done for an i…
Malignant Solid Tumors
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT02421380